Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Comparison Results
Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 12522.00p | 488.40K | xxxxxxxxxxxxx | 11 Buy 1 Hold 1 Sell Strong Buy | £194.22B | 30.25 | 1.67% | Healthcare | |||
 | 1791.00p | 5.25M | xxxxxxxxxxxxx | 3 Buy 7 Hold 3 Sell Hold | £71.92B | 13.23 | 3.28% | Healthcare | |||
 | 1771.00p | 139.59K | xxxxxxxxxxxxx | 5 Buy 1 Hold 0 Sell Strong Buy | £3.89B | 13.61 | 3.61% | Healthcare | |||
 | 228.70p | 166.00 | xxxxxxxxxxxxx | 8 Buy 0 Hold 1 Sell Strong Buy | £2.09B | 5.67 | ― | Healthcare | |||
 | ― | ― | xxxxxxxxxxxxx | ― | ― | ― | ― | ― |
Performance Comparison
GB:AZN
AstraZeneca
12,528.00
2,628.35
26.55%
GB:GSK
GlaxoSmithKline
1,789.50
459.65
34.56%
GB:HIK
Hikma Pharmaceuticals
1,763.00
1.59
0.09%
GB:HCM
HUTCHMED (China)
234.00
-52.00
-18.18%
GB:DPH
Dechra Pharmaceuticals
―
―
―
Pharma & Biotech Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Jul 29, 2025
Sep 01, 2025
159.781
GlaxoSmithKline
Oct 29, 2025
Dec 01, 2025
23.2
Hikma Pharmaceuticals
Aug 07, 2025
Dec 01, 2025
35.874
HUTCHMED (China)
Aug 07, 2025
Dec 01, 2025
1.075
Dechra Pharmaceuticals
―
―
―
―
Pharma & Biotech - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
AstraZeneca - Strong Buy, based on 13 analyst ratings, 11 Buy, 1 Hold, and 1 Sell.
Hikma Pharmaceuticals - Strong Buy, based on 6 analyst ratings, 5 Buy, 1 Hold, and 0 Sell.
HUTCHMED (China) - Strong Buy, based on 9 analyst ratings, 8 Buy, 0 Hold, and 1 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 12,522.00p, and its average 12-month price target is 14,171.00p.
GlaxoSmithKline's stock price is currently 1,791.00p, and its average 12-month price target is 1,673.25p.
Hikma Pharmaceuticals's stock price is currently 1,771.00p, and its average 12-month price target is 2,560.00p.
HUTCHMED (China) 's stock price is currently 228.70p, and its average 12-month price target is 315.34p.
Dechra Pharmaceuticals's stock price is currently N/A, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline currently pays a dividend of 16.00p which represents an annual dividend yield of 3.28%. GlaxoSmithKline's next Ex-dividend date is November 13, 2025 and its next payout date is January 8, 2026.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) does not currently pay dividends.
Dechra Pharmaceuticals does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Pharma & Biotech Stock Events
Stock | Type | Date |
|---|---|---|
AstraZeneca | Earnings Release | Nov 06, 2025 |
GlaxoSmithKline | Ex-Dividend Date | Nov 13, 2025 |
GlaxoSmithKline | Earnings Release | Feb 04, 2026 |
AstraZeneca | Earnings Release | Feb 05, 2026 |
Hikma Pharmaceuticals | Earnings Release | Feb 26, 2026 |